67
Participants
Start Date
August 30, 2023
Primary Completion Date
August 13, 2024
Study Completion Date
August 13, 2024
BGM0504 Administered SC
5 milligrams (mg) BGM0504 administered subcutaneously (SC) once a week.
BGM0504 Administered SC
Experimental: 10 mg BGM0504 10 mg BGM0504 administered SC once a week.
BGM0504 Administered SC
Experimental: 15 mg BGM0504 15 mg BGM0504 administered SC once a week.
Semaglutide Administered SC
"Active Comparator: 1 mg Semaglutide~1 mg semaglutide administered SC once a week"
Placebo Administered SC
Placebo Comparator: Placebo Placebo administered SC once a week.
The Third Xiangya Hospital of Central South University, Changsha
BrightGene Bio-Medical Technology Co., Ltd.
INDUSTRY